Kinesin family member 11 promotes progression of hepatocellular carcinoma via the OCT4 pathway
Authors:
- 30 August 2023
- journal article
- research article
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 23 (3) , 1-14
Abstract
Hepatocellular carcinoma (HCC) is the tumor with the second highest mortality rate worldwide. Recent research data show that KIF11, a member of the kinesin family (KIF), plays an important role in the progression of various tumors. However, its expression and molecular mechanism in HCC remain elusive. Here, we evaluated the potential role of KIF11 in HCC. The effect of KIF11 was evaluated using the hepatocellular carcinoma cell lines, LM3 and Huh7, after genetic or pharmacological treatment. Evaluating the role of KIF11 in the xenograft animal models using its specific inhibitor. The role of KIF11 was systematically evaluated using specimens obtained from the aforementioned animal and cell models after various in vivo and in vitro experiments. The clinicopathological analysis showed that KIF11 was expressed at high levels in patients with hepatocellular carcinoma. Cell experiments in vitro showed that KIF11 deficiency significantly slowed the proliferation of liver tumor cells. And in the experiment using liver cancer cells overexpressing OCT4, overexpression of OCT4 substantially increased the proliferation of tumor cells compared with tumor cells with KIF11 knockdown alone. Both in vitro cell experiment and in vivo xenotransplantation tumor experiment showed that monastrol, an inhibitor of KIF11, could effectively delay the proliferation and migration of tumor cells. Based on these results, KIF11 is expressed at high levels in hepatocellular carcinoma and promotes tumor proliferation in an OCT4-dependent manner. KIF11 may become a therapeutic target for hepatocellular carcinoma, and its inhibitor monastrol may become a clinical antitumor drug.Keywords
This publication has 40 references indexed in Scilit:
- How kinesin motor proteins drive mitotic spindle function: Lessons from molecular assaysSeminars in Cell & Developmental Biology, 2010
- c-Myc Is Dispensable for Direct Reprogramming of Mouse FibroblastsCell Stem Cell, 2008
- Generation of induced pluripotent stem cells without Myc from mouse and human fibroblastsNature Biotechnology, 2007
- Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung CancerClinical Cancer Research, 2007
- Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genesGenes, Chromosomes and Cancer, 2007
- X chromosomal abnormalities in basal-like human breast cancerCancer Cell, 2006
- Gene Expression in the Urinary BladderCancer Research, 2004
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- The C-Terminal Region of the Stalk Domain of Ubiquitous Human Kinesin Heavy Chain Contains the Binding Site for Kinesin Light ChainBiochemistry, 1998
- A nexus between Oct-4 and E1 A: Implications for gene regulation in embryonic stem cellsCell, 1991